Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service.
A podcast on medicine, oncology, & health policy.
Host: Vinay Prasad, MD MPH from University of California San Francisco.
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com
Title
|
Date published
|
|
|
2.08 Questions of the Week: the MKSAP, the USMLE Step 2 CK, & From a Med Student
|
2019-08-22
|
|
|
2.07 Translational Research & Physical Examination Pet Peeves with Dr. Adam Cifu
|
2019-08-16
|
|
|
2.06 Heart Failure, Choosing a Specialty, & the Bayesian Approach with Dr. Frank Harrell
|
2019-08-06
|
|
|
2.05 Reup! Cancer Screening 101 with Dr. Adam Obley
|
2019-07-31
|
|
|
2.04 Reup! Tumor-Treating Fields for Glioblastoma with Dr. Michael Hayes
|
2019-07-30
|
|
|
2.03 Dr. Charles Moertel and the Modern Oncologist & Cancer Screening 101 with Dr. Adam Obley
|
2019-07-23
|
|
|
2.02 BONUS! Improving Access to Prescription Drugs through Policy Change with Dr. Stacie Dusetzina
|
2019-07-17
|
|
|
2.01 Selinexor, ECHELON-2, Parachutes, Tumor-Treating Fields, & MedTwitter
|
2019-07-12
|
|
|
1.68 Voxeletor with Dr. Olson & Humanizing Cancer, Defining Cancer, and more with Dr. David Steensma
|
2019-07-05
|
|
|
1.67 MONALEESA-7 and the Cost of Cancer Drugs with Dr. Stacie Dusetzina
|
2019-06-27
|
|
|
1.66 Employing Medical Writers & Frequentist vs Bayesian Methods with Dr. Allen Pannell
|
2019-06-20
|
|
|
1.65 BONUS! Focusing and Building Your Presence on Twitter
|
2019-06-12
|
|
|
1.64 Effectiveness of Cancer Screening with Dr. Joaquín Chapa and POLO with Dr. Emerson Chen
|
2019-06-06
|
|
|
1.63 POLO, TITAN, & from ASCO: FDA Approval, Surrogate Endpoints, and Patient Experience
|
2019-06-04
|
|
|
1.62 Rates of Cancer Screening, BILCAP Outcry, Waterfall Plots and Response Rate, & Dr. Jeff Sharman
|
2019-05-23
|
|
|
1.61 Postpublication Metrics of RCTs, PCP Appointment Time, Bortezomib, & Dr. Christopher Booth
|
2019-05-15
|
|
|
1.60 I-PREDICT, Flawed Phase I Trials, & the Cost of Drugs with Dr. Daniel Hartung
|
2019-05-09
|
|
|
1.59 BONUS! Should Evidence Come with an Expiration Date? with Palmer Greene
|
2019-05-08
|
|
|
1.58 Magic Mouthwash with Dr. Arjun Gupta & Precision Oncology with Dr. Talal Hilal
|
2019-05-07
|
|
|
1.57 BONUS! Control Arm Quality in RCTs Leading to Anticancer Drug FDA Approval with Dr. Talal Hilal
|
2019-05-02
|
|
|